ISOLATION AND CHARACTERIZATION OF BACTERIOPHAGE WITH LYTIC ACTIVITY AGAINST CARBAPENEM RESISTANCE STRAIN OF KLEBSIELLA PNEUMONIA.


Journal

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
ISSN: 1426-9686
Titre abrégé: Pol Merkur Lekarski
Pays: Poland
ID NLM: 9705469

Informations de publication

Date de publication:
2023
Historique:
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 28 3 2023
Statut: ppublish

Résumé

Aim: Klebsiella pneumonia has emerged as an increasingly important cause of community-acquired nosocomial infections and many of these strains are highly virulent and exhibit a strong propensity to spread. Infections cause by K. pneumonia produces carbapen¬emase (KPC) enzyme and can be difficult to treat since only a few antibiotics are effective against them. Bacteriophage targeting this strain can be an alternative treatment. Characterisation of bacteriophage is utmost important in assisting the application of bacteriophage in phage therapy. Materials and methods: In the present study, the lytic bacteriophage, k3w7, isolated by the host Klebsiella pneumoniae kP2 was characterised using transmission electron microscope (TEM), plaque assay, and restriction digestive enzyme to investigate mor¬phology, host spectrum, bacteriophage life cycle and stability accordingly. Results and conclusions: As shown by TEM, k3w7 was observed to have the characteristic of icosahedral heads 100 nm and contractile sheaths 120 nm suggesting it belongs to the family of myoviridae.The Investigation has done on the phage growth cycle showed a short latent period of 20 min and a burst size of approximately 220 plaque forming units per infected cell. Stability test showed the phage was stable over a wide range of pH and temperatures. According to restriction analysis, k3w7 had 50 -kb double-stranded DNA genome as well as the heterogeneous nature of genetic material. These findings suggest that K3W7 has a potential use in therapy against infections caused by K. pneumonia produces carbapenemase.

Identifiants

pubmed: 36960898
doi: 10.36740/Merkur202301105
doi:

Substances chimiques

Carbapenems 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

35-41

Auteurs

Abeer Ameen Baqer (AA)

BIOTECHNOLOGY DIVISION, DEPARTMENTS OF APPLIED SCIENCES, UNIVERSITY OF TECHNOLOGY, IRAQ.

Norefrina Shafinaz Md Nor (NSM)

DEPARTMENT OF BIOLOGICAL SCIENCES AND BIOTECHNOLOGY, FACULTY OF SCIENCE AND TECHNOLOGY, UNIVERSITI KEBANGSAAN MALAYSIA, MALAYSIA.

Huda Salman Alagely (HS)

BIOTECHNOLOGY RESEARCH CENTER, AL NAHRAIN UNIVERSITY, IRAQ.

Mustafa Musa (M)

MEDICAL INSTRUMENTS ENGINEERING TECHNIQUES, DIJLAH UNIVERSITY COLLEGE, IRAQ.

Nur Adnalizawati Adnan (NA)

FACULTY OF DENTISTRY, UNIVERSITI SAINS ISLAM, MALAYSIA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH